ArticlePloS one2025
Study on the relationship between viral inactivation and alkyl chain length of benzalkonium chloride.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Virus-Dependent Relative Contributions of Citric Acid and Benzalkonium Chloride to the Virucidal Efficacy of Combination Disinfectants.Microorganisms · 2026Article
- From Environmental Threat to Control: A Review of Technologies for Removal of Quaternary Ammonium Compounds from Wastewater.Membranes · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alkyldimethylbenzylammonium chloride (BAC), a quaternary ammonium salt surfactant, is commonly utilized as a sanitizer and disinfectant. Concerns have emerged regarding the increasing global exposure to BAC, emphasizing the need for strategies to maximize its efficacy while minimizing its usage. Therefore, it is crucial to understand BAC's effects on bacteria and viruses, and its mechanism of action. Our previous research demonstrated that BAC micelles solubilizes the lipid bilayer of viruses, significantly enhancing virus inactivation efficacy at concentrations exceeding the critical micelle concentration (CMC). We focused on the alkyl chain length of BAC to elucidate how variations in CMC, driven by differences in alkyl chain length, influence virus inactivation activity. We measured CMC and assessed influenza virus inactivation for benzyldodecyldimethylammonium chloride (C12BAC), benzyltetradecyldimethylammonium chloride (C14BAC), benzylhexadecyldimethylammonium chloride (C16BAC), and their mixtures. The results showed that both BACs with a single alkyl chain length and mixed BACs exhibited significantly enhanced inactivation activity at concentrations of the CMC or above. Notably, BAC mixtures with comparable CMC values showed similar virucidal activity, suggesting that CMC can serve as a useful indicator in designing BAC mixtures aimed at virus inactivation, leading to the development of compositions with enhanced virus inactivation at lower doses. However, when the bactericidal activity of each BAC mixture against E. coli was tested under the same conditions, a significant bactericidal effect, of at least 3 Log10, was observed even at concentrations below CMC. This suggests that the bactericidal activity of BAC is not due to the micellization at CMC, but rather to the contribution of BAC monomers, indicating a distinct difference in the mechanism of action of BAC against viruses and bacteria. Therefore, when formulating BAC-based disinfectants, it is essential to assess the inactivation efficacy against both bacteria and viruses to ensure sufficient virus inactivation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.